Great blog today on AMBS from CEO. But it is not nearly as sure a bet as MNKD is right now. A lot more will be known 6 months from now. Afrezza is going to make it, LymPro is going to its first rodeo. I do hope it does, as Alheimers really needs a direct test rather than a differential dx.